Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa

This study has been completed.
Sponsor:
Information provided by:
UCB Pharma
ClinicalTrials.gov Identifier:
NCT00244387
First received: October 24, 2005
Last updated: September 24, 2014
Last verified: February 2010